3648 results for «2520»

Filter By

3648 results

New strategies in STEMI treatments

20 May 2026 – From EuroPCR 2026

Investigate new strategies in STEMI treatment through data from international registries and clinical trials. This session examines the comparative efficacy of sirolimus versus paclitaxel-coated balloons, plaque modification in calcified lesions, novel cardioprotective techniques during primary PCI, and the role of AI-assisted ECG interpretation in STEMI pathways.

TAVI: head-to-head trials

20 May 2026 – From EuroPCR 2026

This session presents head-to-head comparisons of TAVI devices from recent randomized trials and registries. Highlights include three-year outcomes from the SMART trial, two-year data from the LANDMARK trial on contemporary valves, comparisons of intra- and supra-annular self-expanding valves, evaluations in large annuli, the ALLEGRA trial focusing...

TAVI: head-to-head trials

Lost, crushed, fractured: stent complications in real life

20 May 2026 – From EuroPCR 2026

This session addresses real-world challenges of stent complications including loss, crushing, and fracture during PCI. Through case-based discussions, it explores complex scenarios such as stent dislodgement, embolisation, and management strategies when initial plans evolve into complicated realities.

Lost, crushed, fractured: stent complications in real life

All you need to know about interventional therapies for pulmonary embolism

20 May 2026 – From EuroPCR 2026

Focused on interventional therapies for pulmonary embolism, this session guides on establishing and sustaining Pulmonary Embolism Response Teams (PERT), refining patient selection for intervention, choosing appropriate technologies, and identifying intraprocedural markers indicating successful treatment outcomes.

All you need to know about interventional therapies for pulmonary embolism

Antithrombotic therapy after TAVI: optimal agents, regimens, and patient selection

20 May 2026 – From EuroPCR 2026

This session critically evaluates antithrombotic therapy following TAVI, addressing optimal agents and regimens tailored to patients with and without atrial fibrillation. It also reviews clinical presentations and management of valve thrombosis post-TAVI, using guideline-based approaches and real-world cases to individualize patient care.

Antithrombotic therapy after TAVI: optimal agents, regimens, and patient selection

Unusual complexities, uncommon complications and innovative solutions

20 May 2026 – From EuroPCR 2026

This session showcases innovative solutions to unusual complexities and rare complications in interventional cardiology. Through detailed case presentations, it examines ambiguous CTO management, giant coronary aneurysm complications post-PCI, and unforeseen issues arising from coronary atherectomy for calcified nodules.

Unusual complexities, uncommon complications and innovative solutions

Other valvular and structural interventions

20 May 2026 – From EuroPCR 2026

Covering a spectrum of valvular and structural heart interventions, this session discusses systemic aortic valve TEER in complex congenital cases, compares TAVI and surgical AVR outcomes via meta-analysis, highlights radiation protection advances in complex endovascular repair, and presents combined mitral and tricuspid TEER techniques, novel ultrasound...

Other valvular and structural interventions

Dangers of dissection: the role of ICI

20 May 2026 – From EuroPCR 2026

This session explores the critical role of intracoronary imaging (ICI) in diagnosing and managing coronary artery dissections. Cases include fenestration techniques, stent migration challenges, polytrauma patient management, route selection dilemmas, and intricate procedural navigation to achieve successful outcomes.

Dangers of dissection: the role of ICI

Intracoronary imaging evaluation of stent implantation

20 May 2026 – From EuroPCR 2026

Focusing on intracoronary imaging evaluation of stent implantation, this session presents serial OCT data on plaque characteristics and neoatherosclerosis post-STEMI, the clinical impact of stent malapposition in ACS, long-term apposition dynamics, factors influencing stent expansion in calcified lesions by NIRS-IVUS, and OCT insights into coronary artery...

Intracoronary imaging evaluation of stent implantation

Uncovering ischaemia mechanisms with intracoronary imaging

20 May 2026 – From EuroPCR 2026

This session delves into the complex mechanisms of ischaemia through the lens of intracoronary imaging, highlighting challenging cases such as very-long, complex woven coronary syndromes, unusual ACS presentations, and the nuanced interplay between physiology and imaging in diagnosing angina in pulmonary hypertension with left main compression.

Uncovering ischaemia mechanisms with intracoronary imaging

When transcatheter LAA closure becomes challenging

20 May 2026 – From EuroPCR 2026

This session addresses the technical and clinical challenges encountered during transcatheter left atrial appendage (LAA) closure, including management of peri-device leaks, alternative access routes like transhepatic approaches, complications following surgical closures, and rare procedural adversities such as accidental aortic puncture.

When transcatheter LAA closure becomes challenging

Interventions for heart failure: shock and beyond

20 May 2026 – From EuroPCR 2026

Focused on interventions for heart failure, this session presents data on mitral regurgitation post-alcohol septal ablation, outcomes from high-risk PCI supported by Impella CP, evolving trends in ECMO utilization for cardiogenic shock, and six-month patient outcomes guided by shock team management strategies.

Complex left main patients and PCI

20 May 2026 – From EuroPCR 2026

This session addressed the complexities of left main PCI, focusing on managing hemodynamic uncertainty in high-risk interventions, advanced techniques such as ultra-low contrast rota-tripsy PCI, precise stent positioning, and pragmatic approaches to CHIP cases, emphasizing contrast-sparing strategies and best practice balancing.

Best cases in stable CAD

20 May 2026 – From EuroPCR 2026

This session showcases exemplary cases in stable coronary artery disease, emphasizing complex diagnostic and therapeutic challenges such as ambiguous angiographic findings, refractory vasospastic angina, catastrophic no-reflow phenomena, and the application of physiology-guided PCI and coronary sinus reducers.

New data in DCB outcomes

20 May 2026 – From EuroPCR 2026

Explore emerging evidence on drug-coated balloon (DCB) outcomes, featuring intravascular lithotripsy combined with DCB in calcified small vessels, OCT-guided PCI registries, predictors of angiographic success post-sirolimus-coated balloon angioplasty, and clinical impact in multivessel coronary artery disease management.

New data in DCB outcomes

Complication one: PCI complications occuring during urgent PCI for NSTEMI

20 May 2026 – From EuroPCR 2026

Examine real-world PCI complications encountered during urgent interventions for NSTEMI patients. This session presents a series of complex cases illustrating management strategies for adverse events such as coronary perforations, device issues, and imaging challenges to inform safer procedural practice.

Complex distal LM PCI challenges (trifurcations and more)

20 May 2026 – From EuroPCR 2026

Focusing on the intricacies of complex distal left main PCI, this session covers challenging trifurcation lesions and emergency interventions. It includes IVUS-guided approaches for trifurcation PCI, management of calcified left main trifurcations, and multidisciplinary team rescue strategies for unstable left main bifurcation disease.

Images that speak for themselves

20 May 2026 – From EuroPCR 2026

This visually-driven session presents compelling clinical cases where imaging played a decisive role. Cases include unexpected challenges following transcatheter tricuspid valve replacement, severe hypertension in a young athlete, atypical coronary artery anatomy, critical moments of cardiac arrest, and unique coronary artery findings resembling a spider web.

Complex patients with NSTEMI

20 May 2026 – From EuroPCR 2026

This session addresses the complexity of managing NSTEMI patients with challenging clinical presentations, including concurrent vessel and valve disease, thrombus burden, and atypical angiographic findings. It offers practical strategies for diagnosis and intervention to optimize patient outcomes.

Secondary mitral regurgitation: not all patients are the same

20 May 2026 – From EuroPCR 2026

Examining secondary mitral regurgitation, this session differentiates patient phenotypes and discusses the application of updated guideline recommendations. It offers practical guidance on selecting the appropriate device tailored to individual patient characteristics, supported by detailed case studies.

Secondary mitral regurgitation: not all patients are the same
Didn’t find what you were looking for?